Australian Scientists Identify Enzyme With Role In Heart Attack Damage
This article was originally published in PharmAsia News
Executive SummaryAustralian researchers report that a nasal enzyme has a role in causing damage during a heart attack. Working at the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, the scientists said the acid-containing enzyme is automatically dumped onto bacteria after white cells detect their presence. The enzyme in turn produces an acidic bleach, also used as a common way to get rid of bacteria. Under inflammatory conditions such as heart attack, however, the enzyme is dumped in the wrong place. Scientists also have identified antioxidant nitroxides effective in preventing the enzyme from producing its acid. (Click here for more
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.